Atlas Trials

Yanqiao Zhang

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Yanqiao Zhang

RecordFirmDate
A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E Mutation (NCT07229846)Yanqiao Zhang2026-02-01
A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis（SHR-1210-HLJ-009） (NCT04420130)Yanqiao Zhang2020-08-01
A Trial of SHR-1210 in Combination With AIN457 in Patients With MSS CRC（SHR-1210-AIN457） (NCT04298320)Yanqiao Zhang2020-03-15
A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC ) (NCT03825328)Yanqiao Zhang2019-01-30
A Trial of SHR-1210 in Combination With Apatinib in Patients With Unresectable HCC (NCT03793725)Yanqiao Zhang2019-01-30
Study of Apatinib and Capecitabine Combination to Maintain Treating Metastatic Colorectal Cancer (NCT03132025)Yanqiao Zhang2017-04-30
Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer Patients (NCT01641783)Yanqiao Zhang2012-07-01

Track Yanqiao Zhang automatically

Every clearance here is in the API, with alerts when new ones post.